01 2Dojolvi
02 3UX007
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 3
2018 Revenue in Millions : 1
Growth (%) : 163
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 13
2019 Revenue in Millions : 3
Growth (%) : 295
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 40
2020 Revenue in Millions : 13
Growth (%) : 204
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 56
2021 Revenue in Millions : 40
Growth (%) : 41
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 71
2022 Revenue in Millions : 56
Growth (%) : 27
LOOKING FOR A SUPPLIER?